Electra Therapeutics, Inc.

Nasdaq: ETRAGrowth candidate

22 days public · Biological Products, (No Diagnostic Substances) · $9.04 (-1.09%)

Growth candidate RANKED

/ 100 fit

Confidence75%

Electra Therapeutics, Inc. (ETRA) has been public for 22 days and received an intelligence score of 64 with a deterministic strategy-fit of 69/100 for the Growth strategy.

Intelligence score

/ 100 core

Suggested alloc

30%

cap · your limits

Days public

RECENT

Last price

$9.04

live quote

1d change

-1.09%

session

Why selectedLIVE

EQUENCY Reasoning Engine

+Institutional component score is strong at 81, supported by 3 Schedule 13D/13G disclosures on file with the SEC.
+Narrative component score is 72, driven by 1 8-K filing and 18 insider forms on file with the SEC.

RisksLIVE